ENTICER Trademark

Trademark Overview


On Tuesday, January 23, 2024, a trademark application was filed for ENTICER with the United States Patent and Trademark Office. The USPTO has given the ENTICER trademark a serial number of 98371026. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, February 19, 2025. This trademark is owned by Enara Bio Limited. The ENTICER trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceuticals, namely, pharmaceuticals for the treatment of cancers and tumors in humans; medical preparations, namely, immunotherapeutic agents for the treatment and prevention of cancers and tumors in humans; immunotherapeutic agents for the treatment and prevention of cancers and tumours in humans.

Scientific and technological services and research and design relating thereto in the fields of genetics, immunotherapy, oncology and cancer or tumor therapy; industrial research in the fields of genetics, immunotherapy, oncology and cancer therapy; medical and pharmacological research services; medical research services; research and development of medicines; research and development of immunotherapeutic agents and medicines, oncology and cancer therapeutic agents and medicines.
enticer

General Information


Serial Number98371026
Word MarkENTICER
Filing DateTuesday, January 23, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, February 19, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceuticals, namely, pharmaceuticals for the treatment of cancers and tumors in humans; medical preparations, namely, immunotherapeutic agents for the treatment and prevention of cancers and tumors in humans; immunotherapeutic agents for the treatment and prevention of cancers and tumours in humans.
Goods and ServicesScientific and technological services and research and design relating thereto in the fields of genetics, immunotherapy, oncology and cancer or tumor therapy; industrial research in the fields of genetics, immunotherapy, oncology and cancer therapy; medical and pharmacological research services; medical research services; research and development of medicines; research and development of immunotherapeutic agents and medicines, oncology and cancer therapeutic agents and medicines.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 23, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 23, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEnara Bio Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressOxford, Oxfordshire OX44GA
GB

Trademark Events


Event DateEvent Description
Tuesday, January 23, 2024NEW APPLICATION ENTERED
Tuesday, August 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 23, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 19, 2024ASSIGNED TO EXAMINER
Tuesday, August 20, 2024NON-FINAL ACTION WRITTEN
Tuesday, August 20, 2024NON-FINAL ACTION E-MAILED
Monday, November 4, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, November 4, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, February 19, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 19, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 19, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED